Online Mindfulness-based Stress Reduction Intervention for People With Chronic Pain Waiting for Health Services
20. september 2022 oppdatert av: Diana Zidarov, Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal
Online Mindfulness-based Stress Reduction Intervention for Chronic Pain in Individuals Waiting for Health Care Services: a Study Protocol for a Pilot Randomized Controlled Trial (RCT)
The goal of this project is to explore the feasibility and the efficacy of a online mindfulness-based stress reduction intervention for people with chronic pain waiting for secondary or tertiary health care services
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Faktiske)
60
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Quebec
-
Montreal, Quebec, Canada, H1V2C8
- Association québécoise de la douleur chronique
-
Montreal, Quebec, Canada, H4B 1T3
- Centre de réadaptation Layton-Lethbridge-Mackay
-
Montreal, Quebec, Canada, H4G 2A3
- Hôpital de Verdun
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år til 85 år (Voksen, Eldre voksen)
Tar imot friske frivillige
Nei
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Men and women aged 18-85
- Self-reported diagnosis of chronic non-cancer pain
- Chronic non-cancer pain duration of 3 months or more
- Chronic non-cancer pain experienced during 4 days or more per week
- Average pain intensity of 4 or more out of 10 in the last seven days
- French or English fluency
- Access to Wi-Fi
- Be able to attend a weekly two-hour MBSR virtual session for eight consecutive weeks
Exclusion Criteria:
- Cancer-related chronic pain
- Currently receiving or have received in the last 24 months coordinated care in pain clinics, hospitals or rehabilitation centers.
- Current or recent participation (in the last 12 months and more than 12 sessions) of cognitive-behavioral therapy or MBSR program
- Having an unstable psychological conditions such as depression, bipolar disorder, post-traumatic stress disorder, psychotic disorder
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Mindfulness-based stress reduction intervention
Online 8-week group program, once per week
|
An online mindfulness-based stress reduction intervention will be administered in a group format of maximum 15 participants, once a week for 120 minutes for 8 weeks by an experienced therapist trained in MBSR.
Sessions will include sitting and lying meditation, hatha yoga and a body scan where attention is sequentially focused on different parts of the body.
Individual autonomous practice between 30-45 minutes, 6 times / week will also be recommended.
To support individual autonomous practice, a daily diary and two guided videos (around 35 minutes/each) were created.
|
|
Ingen inngripen: Waiting list
Controls will not receive any intervention during this time.
They are on chronic pain clinics waiting list
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Participants retention rate
Tidsramme: 2 months
|
The percentage of participants who have completed the 8 online MBSR sessions
|
2 months
|
|
Participants participation rate
Tidsramme: 12 months
|
The percentage of participants on waiting lists who agreed to participate in the intervention
|
12 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Patient-Reported Outcomes Measurement Information System Global-10
Tidsramme: Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
|
Change in domains of health and functioning as measured by the PROMIS Global-10, score range is 7-35 with increases in scores meaning better outcome
|
Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
|
|
Patient-Reported Outcomes Measurement Information System 29
Tidsramme: Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
|
Change in 8 health-related quality of life domains as measured by the PROMIS 29.
PROMIS-29 is a generic patient reported outcome measure, which includes four items from each of the seven PROMIS domains (physical function, depression, anxiety, fatigue, sleep disturbance, and ability to participate in social roles and activities, pain interference) and a single item on pain intensity.
Each item has five response options (values 1 to 5), except for the pain intensity item which has eleven response options (values 0 to 10).
A total raw score is computed for each domain as the sum of the response to each question within the domain, leading to seven domain scores, each from 4 to 20.
|
Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
|
|
French-Canadian Chronic Pain Self-Efficacy Scale
Tidsramme: Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
|
The French-Canadian Chronic Pain Self-Efficacy Scale (Lacasse et al., 2015) is a 6-item scale that measures an individual's confidence in his/her ability to manage chronic pain in general and pain-related symptoms.
Items are rated on a 10-point Likert scale ranging from 1 = not at all confident to 10 = entirely confident.
Score range is 6-60 with higher scores reflecting greater chronic pain self-efficacy.
|
Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
|
|
Chronic Pain Acceptance Questionnaire
Tidsramme: Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
|
The Chronic Pain Acceptance Questionnaire (CPAQ-8; Fish et al., 2010 ) is an 8-item scale comprised of two subscales: activity engagement and pain willingness.
Items are scored on a 7-point Likert scale ranging from 0 = never true to 6 = always true.
Score range is 0-48 with increases in scores meaning better outcome.
|
Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
|
|
Global Rating of Change Scale
Tidsramme: 3-month follow-up (week 21)
|
The Global Change Rating Scale (11-point visual analogue scale raging from minus 5 to plus 5) will be used to assess the participants' perception of improvement (or decline) in relation to their self-efficacy in manging pain at the end of the MBSR intervention.
|
3-month follow-up (week 21)
|
|
Pain Catastrophizing Scale
Tidsramme: Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
|
Change in pain catastrophizing as measured by the Pain Catastrophizing Scale (French Canadian version).
PCS is a 13-item measure using a 5-point Likert scale (0=not at all, 4=all the time) with score range between 0-52 with decreases in scores meaning better outcome.
|
Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
|
|
Pain Disability Index
Tidsramme: Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
|
Change in pain disability as measured by the The French-Canadian Pain Disability Index (score range is 0-70 with decreases in scores meaning better outcome)
|
Change from week start of MBSR intervention (week 0) to end of intervention (week 8), 3-month follow-up (week 21)
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
16. juni 2021
Primær fullføring (Faktiske)
20. desember 2021
Studiet fullført (Faktiske)
24. januar 2022
Datoer for studieregistrering
Først innsendt
8. april 2021
Først innsendt som oppfylte QC-kriteriene
8. april 2021
Først lagt ut (Faktiske)
13. april 2021
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
22. september 2022
Siste oppdatering sendt inn som oppfylte QC-kriteriene
20. september 2022
Sist bekreftet
1. september 2022
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- CRIR-1499-1120/multi
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .